Heart Failure: Part 1
Survival Prospects of Contemporary GUCH Patients: Is Heart Failure the New Threat?
Barbara Mulder, The Netherlands
Barbara JM Mulder is Professor of Cardiology in the Academic Medical Center in Amsterdam, the Netherlands. In 2001 she initiated the national registry and DNA bank for congenital heart disease, named CONCOR ( CONgenital CORvitia), in which presently over 16.000 patients have been included. She chaired the European Heart Survey on congenital heart disease with 79 participating centers from 24 countries.. From 2010 until 2012 she was president of the International Society of Adult Congenital Cardiology, ISACHD. At present, she is the president of the Netherlands Society of Cardiology
State of the Art of Heart Failure Treatment in GUCH Patients
Werner Budts, Belgium
Heart Failure: Ask the Experts: Part 2
How would you Treat this Patient?
Case Presenter: Matthias Greutmann, Switzerland
Expert Panel: Karen Stout, USA; John Deanfield, UK, Gruschen Veldtman, USA
Failing Fontan with Protein-Loosing Enteropathy
ccTGA with Moderate Tricuspid Regurgitation and Heart Failure
Pregnant CHD with Heart Failure
Rapid Fire Session: Therapeutic Innovations: Ready for the GUCH Patient
Subcutaneous ICD and Life Vest
Haran Burri, Switzerland
Christof Kolb, Germany
TAVI for the Bicuspid Aortic Valve
Stephan Windecker, Switzerland
Percutaneous Repair of the Tricuspid Valve: On the Horizon?
Francesco Maisano, Switzerland
Assist Devices for the Failing Systemic Right Ventricle
David Crossland, UK
Overcoming Treatment Challenges in CHD-PAH Patients
Presentation and Discussion of Two Challenging Clinical Cases
Never Too Old to be Treated?
Dr. Alexandra C. van Dissel
Academic Medical Center, Amsterdam, The Netherlands
New Drug Therapies for GUCH Patients
Angiotensin Receptor-Neprilysin Inhibitors in Heart Failure from CHD
Karen Stout, USA
NOAC’s in GUCH
Barbara Mulder, The Netherlands
Pulmonary Vasodilators in Fontan Patients
Maurice Beghetti, Switzerland
Can we use the New Pulmonary Vasodilators also in Eisenmenger?
Gerhard Diller, Germany
Oral Anticoagulation: In Whom, When and How?
Stroke in Adults with CHD: Incidence and Cumulative Risks
Sara Thorne, UK
Can we use CHADS-VASC and HAS-BLED Scores to Risk Stratify GUCH Patients
Jolien W. Roos-Hesselink, The Netherlands
Which GUCH Patient with IART Needs Long Term Anticoagulation
Judith Bouchardy, Switzerland
Which Adult Fontan Patient Needs Anticoagulation
Which Cyanotic Patient needs Anticoagulation
Erwin Oechslin, Canada
Dr. Erwin Oechslin is Professor of Medicine at the University of Toronto and Director of the Adult Congenital Heart Disease Program, located at the Peter Munk Cardiac Center, University Health Network, Toronto, Canada.
Dr. Erwin Oechslin was born in Einsiedeln (Switzerland) and graduated from the University of Zurich. After completion of his training in internal medicine and adult cardiology, he dedicated his education to congenital heart disease, which included one year training in pediatric cardiology at the Hospital for Sick Children in Zurich (Switzerland) and a two-year fellowship in Adult Congenital Heart Disease under the supervision of Dr. Gary Webb, Toronto. He returned to the University of Hospital of Zurich in 1998 and restructured the Adult Congenital Heart Disease Program.
He moved to Toronto, Canada, in 2006 and succeeded Dr. Gary Webb as Director of the Adult Congenital Heart Disease Program. He holds the Bitove Family Professorship of Adult Congenital Heart Disease and serves as staff physician in the echo laboratory. He is President of the International Society of Adult Congenital Heart Disease (www.isachd.org) and Past-President of the CACH Network (www.cachnet.ca). He is married to Doris and has three daughters.
Jane Somerville Lecture
The Olympic Spirit in GUCH
John Deanfield, UK
Rapid Fire Session: Difficult Questions in Simple Lesions
A Surgically Closed ASD II in Childhood: Completely Corrected?
Alexander Kadner, Switzerland
Hypertension in Repaired Coarctation: When to Intervene and How to Treat?
Andreas Eicken, Germany
Family Screening in Bicuspide Aortic Valves: Really Necessary?
Julie De Backer, Belgium
Marfan = Sartan?
Romy Franken, The Netherlands
RCA from the Left Coronary Sinus: Who needs Surgery?
René Pretre, Switzerland
The Dilated PA: Is there a Risk of Dissection?
Pastora Gallego, Spain
Bicuspid Aortic Valve: Operate Every Aorta at 5 cm
Pro: Alessandro Giamberti, Italy
Con: Markus Schwerzmann, Switzerland
Every Fallot with Severe Pulmonary Regurgitation needs a New Valve
Pro: Werner Budts, Belgium
Con: Matthias Greutmann, Switzerland
Rapid Fire Session: Simple Questions in Complex Lesions
Everything is Good in Arterial Switches?
Daniel Tobler, Switzerland
I’m a Fontan Patient and want to get Pregnant: Any Concerns?
Lorna Swan, UK
The Adult Fontan Patient with Suspected Hepatic Fibrosis: Do we need Liver Biopsies?
Gruschen Veldtman, USA
Low-Flow Low-Gradient Pulmonary Stenosis in Repaired TOF: Fact or Fiction?
Helmuth Baumgartner, Germany
TPV Options for RVOT Patients
Melody TPV: Past, Present and Future
Dr. Andreas Eicken, Germany
GUCH: Technical Options & Solutions
Prof. Oliver Kretschmar, Switzerland
Living with a Heart Defect
Prescribing PDE-5-Inhibitors for Erectile Dysfunction: Safe in GUCH Patients?
Gerhard Diller, Germany
Lets Talk about Sex
Claudia Franke, Germany
Piercing and Tattoos: A Threat for our Patients?
Philip Moons, Belgium
Depression and Suicide among GUCH Patients: Never Heard of?
Adrienne Kovacs, USA
Sports and GUCH
Competitive Sport with a Dilated Aorta: Really Dangerous?
Christian Schmied, Switzerland
Sudden Cardiac Death in GUCH Patients during Activity: Who is Really at Risk?
Dipen Shah, Switzerland
I want to Dive with my Heart Defect: Any Concerns?
Martin Kraus, Switzerland
The New ACC Recommendations for Competitives Athletes with CHD: Sense or Nonsense?
Harald Gabriel, Austria
Closing Session: Best Abstract Awards
Third Prize – Short Presentation by Winner: High Pulmonary Wedge Pressures Independently Predict Atrial Fibrillation in Patients after Trans-Catheter Closure of Atrial Septal Defect
Lukas Mark Meier, Canada
Second Prize – Short Presentation by Winner: Collagen Turnover Biomarkers and Systemic Right Ventricle Remodeling in Adults with Previous Atrial Switch Procedure for Transposition of the Great Arteries
Magdalena Lipczynska, Poland
First Prize – Short Presentation by Winner: Characteristics and Outcomes of Heart Failure-related Hospitalization in Adults with Congenital Heart Disease
Magalie Ladouceur, France